2020 Foltyn Seminar
A National Lipid Association (NLA) Nutrition and Lifestyle Taskforce reviewed the current scientific evidence to examine the effects of low-carbohydrate and very-low-carbohydrate, including ketogenic, diets on weight loss, dyslipidemia, and other cardiometabolic risk factors, and developed a scientific statement to provide guidance for practicing clinicians on the use of these diets in clinical practice. Based on the available scientific evidence, low-carbohydrate diets may offer short-term (<6 months) benefits, such as weight reduction in adults with overweight or obesity and improved glycemic control in patients with pre-diabetes and type 2 diabetes. However, many of the short-term benefits are not maintained over longer periods of time. The limitations of low-carbohydrate diets, especially very-low-carbohydrate diets, are difficulty with adherence and lack of long-term data on cardiovascular outcomes and safety. Additionally, very-low-carbohydrate diets may severely restrict nutrient dense, carbohydrate-containing foods that are known to be associated with cardiometabolic benefits, including vegetables, fruits, whole grains, seeds and nuts, and legumes.
Please join Dr. Kirkpatrick as she presents the evidence for the effects on cardiometabolic risk factors of low-carb and very-low-carb diets and key recommendations from the NLA scientific statement.
Thursday, October 15, 2020 at 4:00pm to 5:30pmVirtual Event